Denmark's Novo Nordisk SA said Wednesday that it will license an antibody from U.S. biopharma Omeros Corp. for up to $2.1 billion in order to expand its portfolio of therapies for rare diseases.
Denmark's Novo Nordisk SA said Wednesday that it will license an antibody from U.S. biopharma Omeros Corp. for up to $2.1 billion in order to expand its portfolio of therapies for rare diseases.
U.S. private equity entity Advent said Wednesday that it has persuaded 67.55% of shareholders in Swiss chipmaker U-blox Holding AG to sell their stakes, signaling the success of its 1.03 billion Swiss franc ($1.3 billion) takeover offer.
Macquarie Group Ltd. said Wednesday it has increased its stake in London City Airport from 25% to 75%, as the Australian financial firm increases its presence in the growing aviation sector.
Dbay Advisors said Wednesday that it will officially force the remaining shareholders of credit hire and legal services business Anexo to sell their shares after the deadline of its takeover offer worth approximately £71 million ($95 million) ended Tuesday.
Risk management company KRM22 PLC said Wednesday that it has raised approximately £9.2 million ($12.3 million) to primarily pay off a £5.7 million debt taken from its largest shareholder.
MyHealthChecked said Tuesday it has agreed to the conditional disposal of its trading subsidiary Concepta Diagnostics Ltd. to Boots UK Ltd. for approximately £2.4 million ($3.2 million).
Minerals exploration company Richmond Hill Resources began to trade on the junior Alternative Investment Market in London on Wednesday after it raised almost £1.5 million ($2 million).
